Renaissance Capital logo

Minerva Neurosciences Priced, Nasdaq: NERV

Clinical-stage biotech developing treatments for central nervous system diseases.

Industry: Health Care

First Day Return: +0.8%

Industry: Health Care

Clinical-stage biotech developing treatments for central nervous system diseases.
more less
IPO Data
IPO File Date 04/09/2014
Offer Price $6.00
Price Range $6.00 - $6.00
Offer Shares (mm) 5.5
Deal Size ($mm) $33
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 06/30/2014
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $33
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Cambridge, MA, United States
Founded 2007
Employees at IPO 6
Website www.minervaneurosciences.com

Minerva Neurosciences (NERV) Performance